DOI QR코드

DOI QR Code

Neonatal arrhythmias: diagnosis, treatment, and clinical outcome

  • Ban, Ji-Eun (Division of Cardiology, Department of Pediatrics, School of Medicine, Ewha Womans University)
  • Received : 2017.05.28
  • Accepted : 2017.09.04
  • Published : 2017.11.15

Abstract

Arrhythmias in the neonatal period are not uncommon, and may occur in neonates with a normal heart or in those with structural heart disease. Neonatal arrhythmias are classified as either benign or nonbenign. Benign arrhythmias include sinus arrhythmia, premature atrial contraction, premature ventricular contraction, and junctional rhythm; these arrhythmias have no clinical significance and do not need therapy. Supraventricular tachycardia, ventricular tachycardia, atrioventricular conduction abnormalities, and genetic arrhythmia such as congenital long-QT syndrome are classified as nonbenign arrhythmias. Although most neonatal arrhythmias are asymptomatic and rarely life-threatening, the prognosis depends on the early recognition and proper management of the condition in some serious cases. Precise diagnosis with risk stratification of patients with nonbenign neonatal arrhythmia is needed to reduce morbidity and mortality. In this article, I review the current understanding of the common clinical presentation, etiology, natural history, and management of neonatal arrhythmias in the absence of an underlying congenital heart disease.

Keywords

References

  1. Southall DP, Richards J, Mitchell P, Brown DJ, Johnston PG, Shinebourne EA. Study of cardiac rhythm in healthy newborn infants. Br Heart J 1980;43:14-20. https://doi.org/10.1136/hrt.43.1.14
  2. Badrawi N, Hegazy RA, Tokovic E, Lotfy W, Mahmoud F, Aly H. Arrhythmia in the neonatal intensive care unit. Pediatr Cardiol 2009; 30:325-30. https://doi.org/10.1007/s00246-008-9355-4
  3. Kundak AA, Dilli D, Karagol B, Karadag N, Zenciroglu A, Okumus N, et al. Non benign neonatal arrhythmias observed in a tertiary neonatal intensive care unit. Indian J Pediatr 2013;80:555-9. https://doi.org/10.1007/s12098-012-0852-3
  4. Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am 2006;53:85-105, vi. https://doi.org/10.1016/j.pcl.2005.10.004
  5. Jaeggi E, Ohman A. Fetal and neonatal arrhythmias. Clin Perinatol 2016;43:99-112. https://doi.org/10.1016/j.clp.2015.11.007
  6. Nagashima M, Matsushima M, Ogawa A, Ohsuga A, Kaneko T, Yazaki T, et al. Cardiac arrhythmias in healthy children revealed by 24-hour ambulatory ECG monitoring. Pediatr Cardiol 1987;8:103-8. https://doi.org/10.1007/BF02079464
  7. Batra A, J Silka M. Ventricular arrhythmias. Prog Pediatr Cardiol 2000;11:39-45. https://doi.org/10.1016/S1058-9813(00)00034-5
  8. De Rosa G, Butera G, Chessa M, Pardeo M, Bria S, Buonuomo PS, et al. Outcome of newborns with asymptomatic monomorphic ventricular arrhythmia. Arch Dis Child Fetal Neonatal Ed 2006;91:F419-22. https://doi.org/10.1136/adc.2005.092932
  9. Kothari DS, Skinner JR. Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal Ed 2006;91:F136-44. https://doi.org/10.1136/adc.2004.049049
  10. Wren C. Cardiac arrhythmias in the fetus and newborn. Semin Fetal Neonatal Med 2006;11:182-90. https://doi.org/10.1016/j.siny.2005.12.001
  11. Spearman AD, Williams P. Supraventricular tachycardia in infancy and childhood. Pediatr Ann 2014;43:456-60. https://doi.org/10.3928/00904481-20141022-13
  12. Goldman LE, Boramanand NK, Acevedo V, Gallagher P, Nehgme R. Preterm infants with paroxysmal supraventricular tachycardia: presentation, response to therapy, and outcome. J Interv Card Electrophysiol 2001;5:293-7. https://doi.org/10.1023/A:1011468800418
  13. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1621-9. https://doi.org/10.1056/NEJM199112053252306
  14. Sanatani S, Potts JE, Reed JH, Saul JP, Stephenson EA, Gibbs KA, et al. The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 2012;5: 984-91. https://doi.org/10.1161/CIRCEP.112.972620
  15. Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996;131:66-72. https://doi.org/10.1016/S0002-8703(96)90052-6
  16. Dorostkar PC, Silka MJ, Morady F, Dick M 2nd. Clinical course of persistent junctional reciprocating tachycardia. J Am Coll Cardiol 1999;33:366-75. https://doi.org/10.1016/S0735-1097(98)00590-7
  17. Mehta AV, Sanchez GR, Sacks EJ, Casta A, Dunn JM, Donner RM. Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up. J Am Coll Cardiol 1988;11:379-85. https://doi.org/10.1016/0735-1097(88)90106-4
  18. Poutiainen AM, Koistinen MJ, Airaksinen KE, Hartikainen EK, Kettunen RV, Karjalainen JE, et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 1999;20:694-700. https://doi.org/10.1053/euhj.1998.1313
  19. Fenrich AL Jr, Perry JC, Friedman RA. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. J Am Coll Cardiol 1995;25:1195-8. https://doi.org/10.1016/0735-1097(94)00513-P
  20. Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age. J Am Coll Cardiol 2002;39:517-20. https://doi.org/10.1016/S0735-1097(01)01773-9
  21. Knudson JD, Cannon BC, Kim JJ, Moffett BS. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol 2011;32:896-903. https://doi.org/10.1007/s00246-011-0010-0
  22. Salerno JC, Kertesz NJ, Friedman RA, Fenrich AL Jr. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children < 3 or > or =3 years of age. J Am Coll Cardiol 2004;43:438-44. https://doi.org/10.1016/j.jacc.2003.09.031
  23. Sarubbi B, Vergara P, D'Alto M, Calabro R. Congenital junctional ectopic tachycardia: presentation and outcome. Indian Pacing Electrophysiol J 2003;3:143-7.
  24. Villain E, Vetter VL, Garcia JM, Herre J, Cifarelli A, Garson A Jr. Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation 1990;81:1544-9. https://doi.org/10.1161/01.CIR.81.5.1544
  25. Collins KK, Van Hare GF, Kertesz NJ, Law IH, Bar-Cohen Y, Dubin AM, et al. Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol 2009;53:690-7. https://doi.org/10.1016/j.jacc.2008.11.019
  26. Casey FA, McCrindle BW, Hamilton RM, Gow RM. Neonatal atrial flutter: significant early morbidity and excellent long-term prognosis. Am Heart J 1997;133:302-6. https://doi.org/10.1016/S0002-8703(97)70224-2
  27. Woo J, Khan O, Caldarelli L, Williams P. Tachycardia in the Neonate. Pediatr Ann 2015;44:e247-50. https://doi.org/10.3928/00904481-20151012-09
  28. Perry JC. Ventricular tachycardia in neonates. Pacing Clin Electrophysiol 1997;20(8 Pt 2):2061-4. https://doi.org/10.1111/j.1540-8159.1997.tb03628.x
  29. Davis AM, Gow RM, McCrindle BW, Hamilton RM. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. Am Heart J 1996;131:186-91. https://doi.org/10.1016/S0002-8703(96)90068-X
  30. Lee SH, Chen SA, Tai CT, Chiang CE, Wu TJ, Cheng CC, et al. Electropharmacologic characteristics and radiofrequency catheter ablation of sustained ventricular tachycardia in patients without structural heart disease. Cardiology 1996;87:33-41.
  31. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 2010;55:2778-84. https://doi.org/10.1016/j.jacc.2010.02.042
  32. Eliasson H, Sonesson SE, Sharland G, Granath F, Simpson JM, Carvalho JS, et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 2011;124:1919-26. https://doi.org/10.1161/CIRCULATIONAHA.111.041970
  33. Martin TA. Congenital heart block: current thoughts on management, morphologic spectrum, and role of intervention. Cardiol Young 2014; 24 Suppl 2:41-6. https://doi.org/10.1017/S1047951114001358
  34. Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 2013;15:1337-82. https://doi.org/10.1093/europace/eut082
  35. Camm AJ, Janse MJ, Roden DM, Rosen MR, Cinca J, Cobbe SM. Congenital and acquired long QT syndrome. Eur Heart J 2000;21:1232-7. https://doi.org/10.1053/euhj.2000.2222
  36. Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol 2008; 51:2291-300. https://doi.org/10.1016/j.jacc.2008.02.068
  37. Tester DJ, Benton AJ, Train L, Deal B, Baudhuin LM, Ackerman MJ. Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. Am J Cardiol 2010;106:1124-8. https://doi.org/10.1016/j.amjcard.2010.06.022
  38. Horigome H, Nagashima M, Sumitomo N, Yoshinaga M, Ushinohama H, Iwamoto M, et al. Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan. Circ Arrhythm Electrophysiol 2010;3:10-7. https://doi.org/10.1161/CIRCEP.109.882159
  39. Sarkozy A, Brugada P. Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol 2005;16 Suppl 1:S8-20. https://doi.org/10.1111/j.1540-8167.2005.50110.x
  40. Liu N, Ruan Y, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 2008;51:23-30. https://doi.org/10.1016/j.pcad.2007.10.005
  41. Rudic B, Schimpf R, Borggrefe M. Short QT syndrome: review of diagnosis and treatment. Arrhythm Electrophysiol Rev 2014;3:76-9. https://doi.org/10.15420/aer.2014.3.2.76
  42. Pereira R, Campuzano O, Sarquella-Brugada G, Cesar S, Iglesias A, Brugada J, et al. Short QT syndrome in pediatrics. Clin Res Cardiol 2017;106:393-400. https://doi.org/10.1007/s00392-017-1094-1

Cited by

  1. Special Considerations in the Management of Tachyarrhythmias in Neonates and Infants: A Report of Four Cases vol.33, pp.1, 2019, https://doi.org/10.1177/0973217919896193
  2. Retrospective, single‐center case series of neonatal lupus vol.37, pp.3, 2020, https://doi.org/10.1111/pde.14132
  3. Benign arrhythmias in pediatric patients vol.63, pp.7, 2017, https://doi.org/10.5124/jkma.2020.63.7.390
  4. Ventricular Tachycardia in Neonates: A Report of Two Cases and Review of the Literature vol.27, pp.1, 2017, https://doi.org/10.15746/sms.21.003
  5. Camera-based heart rate estimation for hospitalized newborns in the presence of motion artifacts vol.20, pp.1, 2017, https://doi.org/10.1186/s12938-021-00958-5